NovoHip Biolox Ball Head (Novosource) – Mislabeling Concern (2024)
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
NovoHip Biolox Ball Head 32mmL Ref: 1345-2803 NovoHip Total Hip System - NovoHip Total Hip System is a non-cemented hip prosthesis that consists of a 4-part total hip replacement system including femoral stem, femoral head, acetabular poly liner, and acetabular metal (or shell) components.
Brand
Novosource, LLC
Lot Codes / Batch Numbers
UDI-DI 00811382037849, Lot Number CER0023
Products Sold
UDI-DI 00811382037849; Lot Number CER0023
Novosource, LLC is recalling NovoHip Biolox Ball Head 32mmL Ref: 1345-2803 NovoHip Total Hip System - NovoHip Total Hip System i due to Mislabeled: Packaged in a box labeled as 32 long but containing a 28 long head by physical marking, may result in joint instability if implanted. Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Mislabeled: Packaged in a box labeled as 32 long but containing a 28 long head by physical marking, may result in joint instability if implanted
Recommended Action
Per FDA guidance
NovoSource LLC issued Urgent Medical Device Recall letter on 9/13/24 via email. Letter states reason for recall, health risk and action to take: "Immediate Action Discontinue Use: All customers and healthcare providers should immediately discontinue the use of the affected product batches. Surgical teams should not use any Biolox Delta Ceramic Head implants from the mislabeling-affected batches in any hip replacement surgeries. "Return or Segregation of Affected Product: Affected implants should be removed from active inventory and returned to NovoSource. Providers should follow instructions for proper packaging and shipping of the returned products. Any products not yet returned should be clearly labeled as "Do Not Use" and quarantined from inventory until shipment back to NovoSource. Instructions on how to return products will be provided, including the appropriate return address and contact person for support during this process. " For Unused Products: Customers should ensure that all unused products from the affected batches are returned to NovoSource. This will prevent any risk of improper head-liner fitting due to the mislabeling. "For Implanted Products: If the mislabeled product has already been implanted, surgeons should be prepared to monitor the patient for symptoms consistent with the mismatch. A mismatch of a 32 long head implanted into a 28 liner would likely have instability issues. A 28 long head implanted into a 32 liner will likely act very similarly in stability and alignment, while wear should not be catastrophic. The surgeon should monitor the patient to determine if symptoms appear that would result in the need to revise. Actions to Be Taken Pending Corrective or Removal Action: "Stop Usage: Healthcare facilities should stop any further use of the affected product batches pending completion of the recall process. NovoSource will provide updates on the investigation and resolution. "Notification to Surgical Teams: IF IMPLANTED, it is essential
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticeDistribution
As reported by FDA
FL, VA, WV
Page updated: Jan 10, 2026